北美疫苗市场至 2027 年 - 按技术划分的区域分析和预测（重组疫苗、结合疫苗、减毒活疫苗、灭活疫苗和亚单位疫苗以及类毒素疫苗）；疾病适应症（DTP（白喉破伤风类毒素和百日咳）、流感、肝炎、呼吸道合胞病毒（RSV）和其他疾病）；给药途径（口服、注射和其他给药途径）；患者类型（儿童患者和成人患者）和国家/地区
No. of Pages: 142 | Report Code: TIPRE00003512 | Category: Life Sciences
No. of Pages: 142 | Report Code: TIPRE00003512 | Category: Life Sciences
北美人类疫苗市场预计将从 2018 年的 145.66 亿美元增至 2027 年的 245.10 亿美元。预计从 2019 年开始，该市场将以 6.0% 的复合年增长率增长-2027年。
市场的增长是由强制或强制疫苗接种以及疫苗接种率下降等因素推动的。然而，由于预测期内人们对疫苗益处的认识较低，疫苗市场可能会受到影响。
< p>美国加州迪士尼乐园麻疹疫情迫使疫苗接种率下降。事例发生在2014年，麻疹疫情已导致加州约111人患病，并已蔓延到其他六个州以及加拿大和墨西哥。几十年来，疫苗接种一直被安全有效地使用，麻疹数量的增加导致了更多的疫苗接种。孩子们更容易感染这些疾病，因此美国大多数家长都会按时给孩子接种疫苗。
< /p>
此外，疫苗接种费由医疗补助 (Medicaid) 报销，医疗补助 (Medicaid) 疫苗接种的报销额因州而异，但在某些州低至 2 美元。此外，美国疾病控制中心 (CDC) 免疫实践咨询委员会 (ACIP) 也允许使用联合疫苗。这是一种安全有效的措施，可以减少完成儿童免疫计划所需的注射次数。因此，疫苗接种率的下降可能会在预测期内显着提高市场。
预计美国将引领全球市场北美地区市场由于生物制药行业的快速增长。由于技术进步，该行业正在经历快速增长，灵活性的提高和运营成本的降低也促进了市场的增长。此外，该国政府还强制规定可预防疾病的免疫接种和疫苗接种。传染病和寄生虫病患病率的上升也决定了市场的增长，因为这些疾病引起了该国疫苗接种的需求。因此，考虑到上述因素，在预测期内，该国市场的增长可能会在北美地区贡献最大份额。
到 2027 年北美其他地区疫苗市场收入和预测（百万美元）
北美疫苗 - 市场细分
< span>
北美疫苗 - 市场细分
按疾病适应症
北美疫苗 - 市场细分
按
给药途径
北美疫苗 - 市场细分
< span>
按国家/地区
< /p>
提及的公司
Strategic insights for North America Vaccines involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
| Report Attribute | Details |
|---|---|
| Market size in 2018 | US$ 14,566.0 Million |
| Market Size by 2027 | US$ 24,510.0 Million |
| Global CAGR (2019 - 2027) | 6.0% |
| Historical Data | 2016-2017 |
| Forecast period | 2019-2027 |
| Segments Covered |
By 技术
|
| Regions and Countries Covered | 北美
|
| Market leaders and key company profiles |
The regional scope of North America Vaccines refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The List of Companies - North America Vaccines Market
The North America Vaccines Market is valued at US$ 14,566.0 Million in 2018, it is projected to reach US$ 24,510.0 Million by 2027.
As per our report North America Vaccines Market, the market size is valued at US$ 14,566.0 Million in 2018, projecting it to reach US$ 24,510.0 Million by 2027. This translates to a CAGR of approximately 6.0% during the forecast period.
The North America Vaccines Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the North America Vaccines Market report:
The North America Vaccines Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The North America Vaccines Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the North America Vaccines Market value chain can benefit from the information contained in a comprehensive market report.
Office No. 1011, First floor, Farena Corporate Park, Magarpatta-Mundhwa road, Pune - 411028, Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For North America Vaccines Market
